log in
Print | Back

Schwabe, Williamson & Wyatt

Erin Forbes

Erin Forbes

Associate

Expertise

  • IP Litigation
  • Patents
  • Intellectual Property

WSG Practice Industries

Activity

Profile

Erin Forbes works closely with her clients to protect their intellectual property and innovations. Her experience encompasses a broad spectrum of technologies, including small molecule and biologic drug products, biomedical devices, and surgical devices. She litigates all aspects of patent disputes, from pre-suit investigation to trial and appeal.

Prior to law school, Erin worked for the Knight Cancer Institute at Oregon Health & Science University, where she coordinated clinical trials, led a team of research assistants, collaborated with clinicians on a genetic tumor registry studying DNA mutations in cancer patients, and paired patients with clinical trials using novel drugs. She also worked for St. Jude Children’s Research Hospital in Memphis, Tennessee, where she was a laboratory assistant in the pharmacokinetics lab for the Pediatric AIDS Clinical Trials Group.  

Education

  • Chicago-Kent College of Law, Illinois Institute of Technology, Juris Doctor degree (2013)
  • The University of Georgia, Bachelor of Science degree, Biology (2002)
Areas of Practice

Intellectual Property | IP Litigation | Patents

Professional Career

Significant Accomplishments

  • Experienced in Hatch-Waxman Act issues, with over five years of experience representing generic drug companies in patent litigations, including acting as trial counsel.
  • Navigates fact and expert discovery, including document review, drafting and responding to written discovery, drafting expert reports, and taking and defending fact and expert witness depositions.
  • Drafts briefs and prepares for and participates in Markman, summary judgment and Daubert hearings.

Articles

The FCC Funds the COVID-19 Telehealth Program
Schwabe, Williamson & Wyatt, June 2020

  The Federal Communications Commission (“FCC”) established the COVID-19 Telehealth Program (the “Telehealth Program”) on April 2, 2020 in response to the COVID-19 pandemic. The Telehealth Program provides $200 million in funding, appropriated by Congress as part of the CARES Act,[1] to assist certain non-profit and public healthcare providers in making telehealth services available to patients who cannot be seen in person...

Additional Articles

  • Latest Federal Court Cases, 12/16/19
  • Latest Federal Court Cases, 12/9/19
  • Latest Federal Court Cases, 11/25/19
  • Lastest Federal Court Cases, 11/11/19
  • Latest Federal Court Cases, 10/21/19
  • Latest Federal Court Cases, 9/30/19
  • Latest Federal Court Cases, 9/16/19
  • Latest Federal Court Case, 9/9/19
  • Latest Federal Court Cases, 9/3/19
  • Latest Federal Court Cases, 8/19/19
  • Latest Federal Court Cases, 8/5/19
  • Latest Federal Court Cases, 7/15/19
  • Latest Federal Court Cases, 7/8/19
  • Latest Federal Court Cases, 7/1/19
  • Latest Federal Court Cases, 6/24/19
  • Latest Federal Court Cases, 6/17/19
  • Latest Federal Court Cases, 6/3/19
  • Latest Federal Court Cases, 5/20/19
  • Latest Federal Court Cases, 5/13/19
  • Latest Federal Court Cases, 5/6/19
  • Latest Federal Court Cases, 4/22/19
  • Latest Federal Court Cases, 4/1/19
  • Health Care of the Future 2018
  • Fresh From the Bench Library

WSG's members are independent firms and are not affiliated in the joint practice of professional services. Each member exercises its own individual judgments on all client matters.

HOME | SITE MAP | GLANCE | PRIVACY POLICY | DISCLAIMER |  © World Services Group, 2020